AYOXXA Biosystems GmbH
About AYOXXA Biosystems GmbHAYOXXA Biosystems GmbH is an international biotech company based in Cologne (Germany) with offices in Boston (USA) and Singapore. LUNARIS™ is AYOXXA’s innovative, patented beads-on-a-chip technology platform to analyze picogram amounts of multiple biomarkers in biological samples.
Founders: Andreas Schmidt and Dieter Trau
CEO: Rodney Turner
CTO: Markus Zumbansen
CFO: Andreas Richter
Please click here for AYOXXA job opportunities.
FOLLOW AYOXXA BIOSYSTEM:
Tweets by Ayoxxa Biosystem
7 articles with AYOXXA Biosystems GmbH
AYOXXA launches the new LUNARISTM Reader designed to facilitate translational research in academic and industrial laboratories
AYOXXA Biosystems GmbH announces the launch of their next generation LUNARISTM Reader.
Panel composition is harmonized across species to allow translation of results from murine and human samples - from lab to clinic
AYOXXA signs research agreement in the field of ophthalmology with one of the leading pharmaceutical companies
Agreement targets the development of low volume and high sensitivity multiplex assays for aqueous humor protein profiling for biomarker identification and validation in support of drug discovery in ophthalmology
AYOXXA launches LUNARISTM Human & Mouse 6-Plex T Cell Characterization Kits to elucidate T cell differentiation
AYOXXA Biosystems GmbH announced the expansion of its catalogue of kits for fully scalable multiplex protein analysis with the introduction of LUNARISTM Human & Mouse 6-Plex T Cell Characterization Kits.
The assay is optimized for usage on LUNARIS, AYOXXA's innovative multiplex protein analysis system.
AYOXXA Biosystems GmbH Introduces LUNARIS, Its Advanced Fully Integrated Low-Volume Beads-On-A-Chip Multiplex Protein Analysis System